Home Cart 0 Sign in  

[ CAS No. 955400-08-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 955400-08-5
Chemical Structure| 955400-08-5
Structure of 955400-08-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 955400-08-5 ]

Related Doc. of [ 955400-08-5 ]

Alternatived Products of [ 955400-08-5 ]

Product Details of [ 955400-08-5 ]

CAS No. :955400-08-5 MDL No. :MFCD18425620
Formula : C6H14ClNO2 Boiling Point : -
Linear Structure Formula :- InChI Key :ROHMLTGBCWLCIW-UHFFFAOYSA-N
M.W : 167.63 Pubchem ID :22342940
Synonyms :

Calculated chemistry of [ 955400-08-5 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 0
Fraction Csp3 : 1.0
Num. rotatable bonds : 2
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 44.69
TPSA : 30.49 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.22 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : 0.14
Log Po/w (WLOGP) : 0.04
Log Po/w (MLOGP) : -0.31
Log Po/w (SILICOS-IT) : 0.82
Consensus Log Po/w : 0.14

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.84
Solubility : 24.5 mg/ml ; 0.146 mol/l
Class : Very soluble
Log S (Ali) : -0.34
Solubility : 77.2 mg/ml ; 0.461 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.05
Solubility : 15.0 mg/ml ; 0.0897 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.2

Safety of [ 955400-08-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 955400-08-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 955400-08-5 ]

[ 955400-08-5 ] Synthesis Path-Downstream   1~3

YieldReaction ConditionsOperation in experiment
(35)-3-Methoxymethylmorpholine hydrochloride mp: 150-152 C. [alpha]D27: -14.70 (C=0.50, MeOH) IR (KBr): 2964, 2947, 2929, 2887, 2833, 2810, 2789, 2765, 2727, 2698, 2490, 1450, 1311, 1194, 1136, 1111, 1095, 1041 cm-1 NMR (DMSO-d6, delta): 2.94-3224 (2H, m), 3.31 (3H, s), 3.38-3.75 (5H, m), 3.84-3.96 (2H, m), 9.45 (2H, br s)
  • 2
  • [ 955400-08-5 ]
  • (((1S,3’R,6’R,7’S,8’E,11’S,12’R)-6-chloro-11',12'-dimethyl-13',13'-dioxido-15'-oxo-3,4-dihydro-2H-spiro[naphthalene-1,22'-[20]oxa[13]thia[1,14]diazatetracyclo[14.7.2.03,6.019,24]pentacosa[8,16,18,24]tetraen]-7'-yl)oxy)acetaldehyde [ No CAS ]
  • (1S,3’R,6’R,7’S,8’E,11’S,12’R)-6-chloro-7'-(2-((3R)-3-(methoxymethyl)-4-morpholinyl)ethoxy)-11’,12'-dimethyl-3,4-dihydro-2H,15’H-spiro[naphthalene-1,22'-[20]oxa[13]thia[1,14]diazatetracyclo[14.7.2.03,6.019,24]pentacosa[8,16,18,24]tetraen]-15'-one-13',13'-dioxide [ No CAS ]
  • (1S,3’R,6’R,7’S,8’E,11’S,12’R)-6-chloro-7'-(2-((3S)-3-(methoxymethyl)-4-morpholinyl)ethoxy)-11’,12'-dimethyl-3,4-dihydro-2H,15’H-spiro[naphthalene-1,22'-[20]oxa[13]thia[1,14]diazatetracyclo[14.7.2.03,6.019,24]pentacosa[8,16,18,24]tetraen]-15'-one-13',13'-dioxide [ No CAS ]
YieldReaction ConditionsOperation in experiment
With sodium tris(acetoxy)borohydride; In 1,2-dichloro-ethane; at 55.0℃; for 5.0h; To a 100 ml flask was added (((1S,3?R,6?R,TS,8?E,11?S,12R)-6-chioro- ii?. 12?-dimethyi-13?, I 3-dioxido-1 5-oxo-3,4-dihydro-2H-spiro[naphthaiene-i,22?-[2ojoxa[ I 3thia[i , l4idiazatetracycio[14.7.203?6.0?9?24jpentacosa[8. 16,1 8,24jtetrae ni-T-yl)oxy)acetaidehyde (from Example 527, Step 1) (10 mg, 0016 mmoi), DCE (2 in), 3-(nethoxymethyi)morphoiine hydrochloride (Frontier Scientific, Logan. UT)( 11 mg, 0.064 mmol), and sodium triacetoxyborohydride (17 ing, 0080 mrnoi). The reaction was stirred at 55 for 5 hours at which time thereaction was quenched with 0,5 ml of MeOH and 100 ml of saturated sodium bicarbonate. The aqueous solution was extracted with 300 ml of EtOAc and the EtOAc layer was washed with l0() ml of brine. The organic layer was dried over sodium sulfate, filtered and the solvent removed by rotary evaporation. The crude product was purified by reversed phase preparatory HPLC (Geminiml Prep Cu 5I.im column; Phenomenex, Torrance, CA; gradient elution of 10% to 90% MeCN in water, where both solvents contain 0.1% TFA, 45 minute method) to give a 1:1mixture of the title compounds (1.8 mg, 2.4 imoI, 15% yield) as a white film. ?H NMR(400MHz, CD2CI2) oe 8.11 (br. s., IH), 7.70 (d,J=8.6Hz, IH), 7.17 (dd, J:::2.2, 8.5 Hz, 11-1), 7.09 (d, J=2.3 Hz, 11-1), 6.91 (s, 21-1), 6.83 (s, 11-1), 5.98 5.77 (iii. 1H). 5.62 - 5.45 (m, IH), 4.26 (d, J:::7,4 Hz, 1H), 4,08 (s, 2H), 4,01 3.89 (m, 4H), 3.88 - 3,73 (m, 5H), 3.69 (d, J=14.5 Hz, 2H), 3.64 3.43 (in, 4H), 337 (in,1.5H), 3.36 (in, 1.5H), 3.24 (d, J=14.3 Hz, 2H), 3.04 (dcl, J=10.1, 15.4 Hz, 1H),2.84 - 2.69 (in, 2H), 2.49 2.39 (in, 11-1), 2.38 - 2.26 (m, 1H), 2.23 1.89 (in, 61-I).1.88 - 1.75 (m, 311), 1.75 - 1.62 (mi. 1H). 1.45 (d, J:::7.O Hz,3H), 1.42 - 1.35 (in,1H), 1.08-0.91 (m, 3H). m/z (ESI, +ve ion) 756.4 (M+H).
  • 3
  • [ 955400-08-5 ]
  • lithium 3-(6,8-difluoroimidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoroethyl)pyrazolo[4,3-c]pyridine-6-carboxylate [ No CAS ]
  • [3-(6,8-difluoroimidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoroethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(3-methoxymethylmorpholin-4-yl)methanone [ No CAS ]
YieldReaction ConditionsOperation in experiment
2% With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine; In N,N-dimethyl acetamide; at 20.0℃; for 0.5h; General procedure: To a solution of compound R or V (1 equiv.) in DMA (0.1 M) were added compound B (1 .3 equiv.), diisopropylethylamine (3 equiv.) and BOP (1.5 equiv.). The reaction mixture was stirred 30min at rt. The reaction mixture was diluted with AcOEt, washed with water and brine, dried over magnesium sulfate, then concentrated. The resulting crude mixture was purified by flash chromatography to afford compound F or K.
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 955400-08-5 ]

Ethers

Chemical Structure| 626220-76-6

[ 626220-76-6 ]

(R)-1-Methoxypropan-2-amine hydrochloride

Similarity: 0.68

Chemical Structure| 78531-29-0

[ 78531-29-0 ]

1,3-Dimethoxypropan-2-amine

Similarity: 0.68

Chemical Structure| 1290136-94-5

[ 1290136-94-5 ]

2-(Methoxymethyl)azetidine

Similarity: 0.68

Chemical Structure| 688809-98-5

[ 688809-98-5 ]

2-(Methoxymethyl)piperidine hydrochloride

Similarity: 0.67

Chemical Structure| 688809-99-6

[ 688809-99-6 ]

(R)-2-(Methoxymethyl)piperidine hydrochloride

Similarity: 0.67

Related Parent Nucleus of
[ 955400-08-5 ]

Aliphatic Heterocycles

Chemical Structure| 1542268-31-4

[ 1542268-31-4 ]

(3R,5R)-3,5-Dimethylmorpholine hydrochloride

Similarity: 0.96

Chemical Structure| 211053-49-5

[ 211053-49-5 ]

(R)-3-Hydroxymethylmorpholine

Similarity: 0.96

Chemical Structure| 256518-81-7

[ 256518-81-7 ]

3,5-Dimethylmorpholine hydrochloride

Similarity: 0.96

Chemical Structure| 1022094-03-6

[ 1022094-03-6 ]

(S)-3-Methylmorpholine hydrochloride

Similarity: 0.96

Chemical Structure| 953780-78-4

[ 953780-78-4 ]

(R)-3-Methylmorpholine hydrochloride

Similarity: 0.96

Morpholines

Chemical Structure| 211053-49-5

[ 211053-49-5 ]

(R)-3-Hydroxymethylmorpholine

Similarity: 0.96

Chemical Structure| 256518-81-7

[ 256518-81-7 ]

3,5-Dimethylmorpholine hydrochloride

Similarity: 0.96

Chemical Structure| 1022094-03-6

[ 1022094-03-6 ]

(S)-3-Methylmorpholine hydrochloride

Similarity: 0.96

Chemical Structure| 953780-78-4

[ 953780-78-4 ]

(R)-3-Methylmorpholine hydrochloride

Similarity: 0.96

Chemical Structure| 211053-50-8

[ 211053-50-8 ]

(S)-Morpholin-3-ylmethanol

Similarity: 0.96